VYNE Therapeutics' earnings beat is likely to positively impact investor sentiment, as historical data shows a positive correlation between earnings beats and subsequent share price performance. The company's ability to outperform earnings estimates and increase revenue from the previous year suggests operational efficiency and growth, which are positive indicators for investors.